HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
Stay updated with breaking news from Pivotal Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154 Company anticipates topline results from this crossover pivotal study late in the second quarter of 2024 ...
MINNEAPOLIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people...
/PRNewswire/ -- The "Surgical Adhesion Barriers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...